Testicular cancer treatment evaluation in pediatric outpatients attending oncology service of two institutes in mexico city

• In: Posters: Social and Administrative Pharmacy Section
• At: Bangkok (Thailand) (2014)
• Type: Poster
• Poster code: POSSAPS003
• By: ALTAGRACIA-MARTíNEZ, Marina (Metropolitan Autonomous University Campus Xochimilco, Biological Systems, Mexico, Mexico)
• Co-author(s): Contreras-Ruiz, Osvaldo (Metropolitan Autonomous University Campus Xochimilco, Mexico, Mexico)
  Landero-Huerta, Daniel Adrián (Metropolitan Autonomous University Campus Xochimilco, Mexico, Mexico)
  Piñonez-Cruz, Brenda (Metropolitan Autonomous University Campus Xochimilco, Mexico, Mexico)
  Rodríguez-Villar, Karen (Metropolitan Autonomous University Campus Xochimilco, Mexico, Mexico)
  Kravzov-Jinich, Jaime (Metropolitan Autonomous University Campus Xochimilco, Mexico, Mexico)
  
• Abstract:

  Background: In Mexico, cancer is one of the leading causes of death. Testicular cancer (TC) is the most frequent type of cancer in male patients from 14 to 45 years old. Health institutions have designed and implemented Practice Clinical Guidelines for the Diagnosis and Treatment of testicular cancer (PCGDTTC) in patients of all ages. An early..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login